Get the Stockscreener App
72.67
1.42%
-1.05
Pre-market:
72.25
-0.42
-0.58%
Insmed Inc stock is traded at $72.67, with a volume of 1.70M.
It is down -1.42% in the last 24 hours and down -2.51% over the past month.
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.
See More
Previous Close:
$73.72
Open:
$73.5
24h Volume:
1.70M
Relative Volume:
1.04
Market Cap:
$13.00B
Revenue:
$342.96M
Net Income/Loss:
$-864.29M
P/E Ratio:
-13.79
EPS:
-5.27
Net Cash Flow:
$-636.03M
1W Performance:
+2.93%
1M Performance:
-2.51%
6M Performance:
+184.53%
1Y Performance:
+195.17%
1-Day Range:
$71.17
$73.95
1-Week Range:
$64.86
$74.32
52-Week Range:
$21.92
$80.53
Insmed Inc Stock (INSM) Company Profile
Name
Insmed Inc
Sector
Industry
Phone
908-977-9900
Address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Compare INSM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| INSM | 72.67 | 13.00B | 342.96M | -864.29M | -636.03M | -5.27 |
| VRTX | 451.23 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 743.35 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.82 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.79 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.14 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-15-24 | Initiated | Wolfe Research | Outperform |
| Dec-08-23 | Initiated | Wells Fargo | Overweight |
| Nov-20-23 | Resumed | JP Morgan | Overweight |
| Jul-26-23 | Initiated | Guggenheim | Buy |
| Dec-09-22 | Initiated | Mizuho | Buy |
| Dec-07-22 | Initiated | Barclays | Overweight |
| Nov-18-22 | Initiated | BofA Securities | Buy |
| Apr-27-22 | Initiated | Goldman | Buy |
| Dec-06-21 | Initiated | JP Morgan | Overweight |
| Oct-19-21 | Resumed | Monness Crespi & Hardt | Buy |
| Oct-19-21 | Resumed | Morgan Stanley | Overweight |
| Oct-08-21 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Dec-17-20 | Initiated | Berenberg | Buy |
| Oct-12-20 | Resumed | Stifel | Buy |
| Sep-03-19 | Initiated | Goldman | Buy |
| Apr-09-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-15-19 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jan-17-19 | Upgrade | Goldman | Neutral → Buy |
| Jan-02-19 | Initiated | Canaccord Genuity | Buy |
| Aug-06-18 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jul-23-18 | Initiated | Goldman | Neutral |
| Apr-23-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-21-18 | Initiated | Morgan Stanley | Overweight |
| Jan-18-18 | Initiated | Credit Suisse | Neutral |
| Sep-05-17 | Reiterated | Evercore ISI | Outperform |
| Aug-17-17 | Initiated | Evercore ISI | Outperform |
| Jul-11-17 | Initiated | Robert W. Baird | Outperform |
| Mar-15-16 | Initiated | Stifel | Buy |
| Nov-09-15 | Downgrade | UBS | Buy → Neutral |
| Oct-06-15 | Reiterated | H.C. Wainwright | Buy |
| Jun-09-15 | Initiated | Citigroup | Neutral |
| Mar-26-14 | Reiterated | HC Wainwright | Buy |
View All
Insmed Inc Stock (INSM) Latest News
Insmed Incorporated (NASDAQ:INSM) Stock Holdings Lifted by Jennison Associates LLC - MarketBeat
Insmed (NASDAQ:INSM) Shares Gap UpHere's Why - MarketBeat
Energizer, C3.ai, Insmed And Other Big Stocks Moving Higher On Tuesday - Benzinga
Insmed gains after ending $500M sales pact with Leerink - MSN
Insmed stock gains as $500M sales pact ends (INSM:NASDAQ) - Seeking Alpha
Insmed Incorporated (NASDAQ:INSM) is First Turn Management LLC's 3rd Largest Position - MarketBeat
Oppenheimer Asset Management Inc. Grows Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed's Options: A Look at What the Big Money is Thinking - Benzinga
Analysts Set Insmed Incorporated (NASDAQ:INSM) Price Target at $83.07 - MarketBeat
Victory Capital Management Inc. Buys 308,819 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
WCM Investment Management LLC Purchases 54,806 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Notable Monday Option Activity: INSM, MARA, ALGM - Nasdaq
Insmed stock target reduced, keeps Outperform on Q3 report By Investing.com - Investing.com Canada
TimesSquare Capital Management LLC Invests $35.32 Million in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Principal Financial Group Inc. Acquires 214,130 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga
Fiera Capital Corp Sells 13,112 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Van ECK Associates Corp Invests $9.14 Million in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Citizentribune
Insmed Issues $4.6M in Stock Options to New Hires at $68.32 Share Price | INSM Stock News - StockTitan
Insmed To Present at November 2024 Investor Conferences - Marketscreener.com
Insmed (INSM) Set for Major Healthcare Conference Circuit: 4 Key Investor Events in November | INSM Stock News - StockTitan
17,682 Shares in Insmed Incorporated (NASDAQ:INSM) Acquired by Harbor Capital Advisors Inc. - MarketBeat
Insmed's SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada
Insmed's SWOT analysis: rare disease biotech stock poised for growth - Investing.com
New York State Common Retirement Fund Sells 29,520 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
INSMInsmed, Inc. Latest Stock News & Market Updates - StockTitan
Insmed (INSM) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Emerald Advisers LLC Buys 49,540 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates - MSN
Insmed (NASDAQ:INSM) Announces Earnings Results - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Q3 2024 Earnings Call Transcript - Insider Monkey
Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates - MSN
Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN
Earnings call: Insmed reports strong Q3 growth, eyes brensocatib launch - Investing.com
Earnings call: Insmed reports strong Q3 growth, eyes brensocatib launch By Investing.com - Investing.com UK
Do You Believe in the Growth Potential of Insmed (INSM)? - Yahoo Finance
Truist Financial Reaffirms Buy Rating for Insmed (NASDAQ:INSM) - MarketBeat
Insmed Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Decoding Insmed Inc (INSM): A Strategic SWOT Insight - GuruFocus.com
Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Reven - GuruFocus.com
Insmed: Q3 Earnings Snapshot - The Advocate
Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update - PR Newswire
How to play biotech stocks: Insmed and Wave Life Sciences - Yahoo Finance
Insmed Incorporated (NASDAQ:INSM) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat
Novo Holdings A S Lowers Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Shares Acquired by Creative Planning - MarketBeat
Insmed Inc Stock (INSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
6.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):